DP
David Patience
Chief Financial Officer

David Patience insider trades: TriSalus Life Sciences (TLSI) stock buys and sales

Chief Financial Officer, TriSalus Life Sciences Last trade Feb 23, 2026 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$15K
Bought, last 12 months
1 buy
14
Open-market trades
since 2023
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 23, 2026TLSI↑ Buy$15K
Apr 1, 2025AXDX↓ Sell$5K
Feb 26, 2025AXDX↓ Sell$583
Apr 9, 2024AXDX↓ Sell$12K
Feb 26, 2024AXDX↓ Sell$336
Dec 13, 2023AXDX↓ Sell$426
Nov 13, 2023AXDX↓ Sell$540
Oct 13, 2023AXDX↓ Sell$560
Sep 13, 2023AXDX↓ Sell$627
Aug 14, 2023AXDX↓ Sell$646
Jul 13, 2023AXDX↓ Sell$635
Jun 13, 2023AXDX↓ Sell$1K
May 15, 2023AXDX↓ Sell$843
Apr 13, 2023AXDX↓ Sell$746

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TLSI insiders

Open-market trades in the last 12 months

About David Patience's insider trades

David Patience is Chief Financial Officer at TriSalus Life Sciences (TLSI). Since Apr 13, 2023, David has reported 1 open-market purchase worth $15K and 13 sales worth $24K on SEC Form 4. In the last 12 months: 1 buy ($15K).

Their filings also include option exercises (13 filings), grants and awards (8 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TLSI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.